Clinical trialNCT07527650RecruitingPhase 2Interventional

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

SponsorHanmi Pharmaceutical Company LimitedEnrollment180T2DMType 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Desert Clinical Research
Mesa, Arizona, United States
Gerald Shockey
Recruiting
Accel Research Sites - Deland
DeLand, Florida, United States
Bruce Rankin
Recruiting
Adventhealth Translational Research Institute
Orlando, Florida, United States
Richard Edwin Pratley
Not, yet, recruiting
Charter Research
Orlando, Florida, United States
Mary Hilal Quarterman
Recruiting
K2 Medical Research the Villages Llc
The Villages, Florida, United States
Craig T Curtis
Recruiting
Centricity Research Irt - Dba Iact Health Columbus Piedmont
Columbus, Georgia, United States
Steven Leichter
Recruiting
the South Bend Clinic
South Bend, Indiana, United States
Rita Schmid
Recruiting
Jefferson City Medical Center
Jefferson City, Missouri, United States
Benjamin Cook
Recruiting
Clay Platte Family Medicine
Kansas City, Missouri, United States
Scott Kuennen
Recruiting
Methodist Physicians Clinic
Fremont, Nebraska, United States
Thomas Wolf
Recruiting
Santa Rosa Medical Centers of Nevada
Las Vegas, Nevada, United States
Syed Pervaiz
Recruiting
Lucas Research, Inc.
Morehead City, North Carolina, United States
Kathryn Jean Lucas
Recruiting
Centricity Research Columbus
Columbus, Ohio, United States
Sridhar Guduri
Recruiting
Olympus Family Medicine
Salt Lake City, Utah, United States
Jared Probst
Recruiting
Manassas Clinical Research Center
Manassas, Virginia, United States
Nabil Saleh Andrawis
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

HM15275Placebo of HM15275

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 May 2026
Primary completion: 31 Oct 2027
Completion: 31 Oct 2027
Last update posted: 17 Aug 2026
Registered enrollment: 180
Registry id: NCT07527650

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.